Primary Recipient

IMMUNOMEDICS, INC.

Amount

$192,688.00

Award Date

6/01/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

This project will develop two new agents that target the cancer marker, insulin-like growth factor 1 receptor, for the treatment of kidney cancer.